Weening Michael 4
4 · CALIX, INC · Filed Nov 3, 2025
Insider Transaction Report
Form 4
CALIX, INC(CALX)
Weening Michael
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-10-30−200,000→ 74,000 totalExercise: $7.84Exp: 2029-11-27→ Common Stock (200,000 underlying) - Sale
Common Stock
2025-10-30$64.63/sh−150,000$9,694,200→ 66,117 total - Exercise/Conversion
Common Stock
2025-11-03$7.84/sh+74,000$580,160→ 90,117 total - Exercise/Conversion
Common Stock
2025-10-30$7.84/sh+200,000$1,568,000→ 216,117 total - Sale
Common Stock
2025-11-03$67.42/sh−74,000$4,989,102→ 16,117 total - Sale
Common Stock
2025-10-30$67.55/sh−50,000$3,377,280→ 16,117 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-03−74,000→ 0 totalExercise: $7.84Exp: 2029-11-27→ Common Stock (74,000 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.00, inclusive. Full information on the number of shares sold at each sale price is available upon request.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $67.35 to $67.93, inclusive. Full information on the number of shares sold at each sale price is available upon request.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.245 to $69.450, inclusive. Full information on the number of shares sold at each sale price is available upon request.
- [F4]100% of the shares subject to the option were fully vested and exercisable on November 27, 2023.